Building on Record Setting 2023
Camber launched 33 new generic products in 2023. Our portfolio now has over 150 generic products, with over 600 SKUs, across numerous therapeutic areas and formulation types. Watch our short video (96 seconds) highlighting major accomplishments from 2023!
Recent articles
- Camber Specialty Marks First Day 1 Injectable Launch
- New to Camber’s Portfolio: Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets
- Camber Pharmaceuticals Honored as Second Merit Finalist at 2026 DIANA Awards
- Camber Launches Nitazoxanide Tablets
- Cisatracurium Besylate Injection, USP Added to Camber’s Portfolio
- Camber Welcomes Summer 2026 Intern Class